DeviceTalks

Celine Martin discusses atrial fibrillation, neurovascular and where J&J Medtech may be going next

12.10.2022 - By DeviceTalksPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

In this episode, Celine Martin, company group chairman, Cardiovascular & Specialty Solutions Group, offers insights from her career at Johnson & Johnson. What are the four variables you need to consider to thrive in a global company. Martin also shares insights on cardiac ablation, neurovascular, and where the company is headed following the acquisition of Abiomed.

Paul Grand, CEO of Medtech Innovator, joins as a co-host offering insights on Chris Newmarker’s Newsmakers – Moon Surgical, Butterfly Network, Medtronic, Avail Medsystems, Dexcom, and Fresenius Medical. Grand shares a personal connection to one of the companies.

Grand, Newmarker and Tom Salemi also share their thoughts on the retirement of Mike Mussallem, CEO of Edwards Lifesciences.

Thank you to Nordson Medical for sponsoring this episode. Go to NordsonMedical.com for more information.

Thank you for listening to the DeviceTalks Weekly Podcast

You can subscribe to this podcast on any major podcast player.

More episodes from DeviceTalks